Meeting of the Secretary's Advisory Committee on Human Research Protections, 34689 [E7-12229]
Download as PDF
Federal Register / Vol. 72, No. 121 / Monday, June 25, 2007 / Notices
FOR FURTHER INFORMATION CONTACT:
Sandra M. Peay, Contact Representative
or Renee Hallman, Contact
Representative Federal Trade
Commission Premerger Notification
Office, Bureau of Competition, Room H–
303, Washington, DC 20580, (202) 326–
3100.
By direction of the Commission.
Donald S. Clark
Secretary.
[FR Doc. 07–3100 Filed 06–22–07; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Secretary’s Advisory
Committee on Human Research
Protections
Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
AGENCY:
SUMMARY: Pursuant to Section 10(a) of
the Federal Advisory Committee Act,
U.S.C. Appendix 2, notice is hereby
given that the Secretary’s Advisory
Committee on Human Research
Protections (SACHRP) will hold its
thirteenth meeting. The meeting will be
open to the public.
DATES: The meeting will be held on
Monday July 30, 2007, from 8:30 a.m.
until 5 p.m. and Tuesday, July 31, 2007,
from 8:30 a.m. until 4:45 p.m.
ADDRESSES: The Sheraton National
Hotel, 900 South Orme Street,
Arlington, VA 22204. Phone: 703–521–
1900.
FOR FURTHER INFORMATION CONTACT:
Bernard Schwetz, D.V.M., PhD, Director,
Office for Human Research Protections
(OHRP), or Catherine Slatinshek,
Executive Director, Secretary’s Advisory
Committee on Human Research
Protections; Department of Health and
Human Services, 1101 Wootton
Parkway, Suite 200, Rockville, MD
20852; 240–453–8139; fax: 240–453–
6909; e-mail address:
sachrp@osophs.dhhs.gov.
Under the
authority of 42 U.S.C. 217a, Section 222
of the Public Health Service Act, as
amended, SACHRP was established to
provide expert advice and
recommendations to the Secretary of
Health and Human Services and the
Assistant Secretary for Health on issues
and topics pertaining to or associated
with the protection of human research
subjects.
On July 30, 2007, SACHRP will
receive and discuss updated
sroberts on PROD1PC70 with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
23:08 Jun 22, 2007
Jkt 211001
information and a report from the
Subpart A Subcommittee on issues
involving the application of subpart A
of 45 CFR part 46 in the current research
environment. This subcommittee was
established by SACHRP at its October
4–5, 2006, meeting. The Committee also
will receive a report and action list from
the Subcommittee on Inclusion of
Individuals with Impaired DecisionMaking in Research. This subcommittee
was formed as a result of discussions
during the July 31–August 1, 2006,
SACHRP meeting. In addition, the
Committee will receive a briefing on the
Final Report of the National Conference
on Institutional Review Boards, held in
Washington, DC in November 2006.
On July 31, 2007, the Committee will
receive presentations and hear
discussions from representatives on a
panel that will examine issues involving
informed consent, including length and
complexity of informed consent
documents, views from subjects on
these issues, and insights from the
human subjects research community.
The Committee will also hear
presentations from panelists on
diversity of ethnic and racial
representation in clinical trials.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend the meeting and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the designated contact persons.
Members of the public will have the
opportunity to provide comments on
both days of the meeting. Public
comment will be limited to five minutes
per speaker. Any members of the public
who wish to have printed materials
distributed to SACHRP members for this
scheduled meeting should submit
materials to the Executive Director,
SACHRP, prior to the close of business
Friday, July 20, 2007. Information about
SACHRP and the draft meeting agenda
will be posted on the SACHRP Web site
at: https://www.hhs.gov/ohrp/sachrp/
index.html.
Dated: June 20, 2007.
Bernard A. Schwetz,
Director, Office for Human Research
Protections, Executive Secretary, Secretary’s
Advisory Committee on Human Research
Protections.
[FR Doc. E7–12229 Filed 6–22–07; 8:45 am]
BILLING CODE 4150–36–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: Notice is hereby given that
the Office of Research Integrity (ORI)
and the Assistant Secretary for Health
have taken final action in the following
case:
Joy Bryant, University of Oklahoma
Health Sciences Center: Based on the
report of an investigation conducted by
the University of Oklahoma Health
Sciences Center (OUHSC) and
additional analysis conducted by the
Office of Research Integrity during its
oversight review, the U.S. Public Health
Service (PHS) found that Ms. Joy Bryant,
Tribal Efforts Against Lead (TEAL)
phlebotomist, OUHSC, engaged in
scientific misconduct in research
supported by National Institute of
Environmental Health Sciences
(NIEHS), National Institutes of Health
(NIH), grant R01 ES008755.
Specifically, Ms. Bryant falsified
research in the TEAL study by
substituting or conspiring with another
phlebotomist to substitute her blood or
blood of another phlebotomist for blood
samples of 10–15 child participants in
the TEAL study.
Ms. Bryant has entered into a
Voluntary Exclusion Agreement
(Agreement) in which she has
voluntarily agreed, for a period of three
(3) years, beginning on May 30, 2007:
(1) To exclude herself from any
contracting or subcontracting with any
agency of the United States Government
and from eligibility or involvement in
nonprocurement programs of the United
States Government as defined in HHS’
implementation of OMB Guidelines to
Agencies on Governmentwide
Debarment and Suspension at 2 CFR
part 376, et seq.; and
(2) to exclude herself from serving in
any advisory capacity to PHS, including
but not limited to service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John E. Dahlberg,
Acting Director, Office of Research Integrity.
[FR Doc. E7–12173 Filed 6–22–07; 8:45 am]
BILLING CODE 4150–31–P
Frm 00027
Fmt 4703
34689
Sfmt 4703
E:\FR\FM\25JNN1.SGM
25JNN1
Agencies
[Federal Register Volume 72, Number 121 (Monday, June 25, 2007)]
[Notices]
[Page 34689]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-12229]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Secretary's Advisory Committee on Human Research
Protections
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Pursuant to Section 10(a) of the Federal Advisory Committee
Act, U.S.C. Appendix 2, notice is hereby given that the Secretary's
Advisory Committee on Human Research Protections (SACHRP) will hold its
thirteenth meeting. The meeting will be open to the public.
DATES: The meeting will be held on Monday July 30, 2007, from 8:30 a.m.
until 5 p.m. and Tuesday, July 31, 2007, from 8:30 a.m. until 4:45 p.m.
ADDRESSES: The Sheraton National Hotel, 900 South Orme Street,
Arlington, VA 22204. Phone: 703-521-1900.
FOR FURTHER INFORMATION CONTACT: Bernard Schwetz, D.V.M., PhD,
Director, Office for Human Research Protections (OHRP), or Catherine
Slatinshek, Executive Director, Secretary's Advisory Committee on Human
Research Protections; Department of Health and Human Services, 1101
Wootton Parkway, Suite 200, Rockville, MD 20852; 240-453-8139; fax:
240-453-6909; e-mail address: sachrp@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service Act, as amended, SACHRP was
established to provide expert advice and recommendations to the
Secretary of Health and Human Services and the Assistant Secretary for
Health on issues and topics pertaining to or associated with the
protection of human research subjects.
On July 30, 2007, SACHRP will receive and discuss updated
information and a report from the Subpart A Subcommittee on issues
involving the application of subpart A of 45 CFR part 46 in the current
research environment. This subcommittee was established by SACHRP at
its October 4-5, 2006, meeting. The Committee also will receive a
report and action list from the Subcommittee on Inclusion of
Individuals with Impaired Decision-Making in Research. This
subcommittee was formed as a result of discussions during the July 31-
August 1, 2006, SACHRP meeting. In addition, the Committee will receive
a briefing on the Final Report of the National Conference on
Institutional Review Boards, held in Washington, DC in November 2006.
On July 31, 2007, the Committee will receive presentations and hear
discussions from representatives on a panel that will examine issues
involving informed consent, including length and complexity of informed
consent documents, views from subjects on these issues, and insights
from the human subjects research community. The Committee will also
hear presentations from panelists on diversity of ethnic and racial
representation in clinical trials.
Public attendance at the meeting is limited to space available.
Individuals who plan to attend the meeting and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the designated contact persons. Members
of the public will have the opportunity to provide comments on both
days of the meeting. Public comment will be limited to five minutes per
speaker. Any members of the public who wish to have printed materials
distributed to SACHRP members for this scheduled meeting should submit
materials to the Executive Director, SACHRP, prior to the close of
business Friday, July 20, 2007. Information about SACHRP and the draft
meeting agenda will be posted on the SACHRP Web site at: https://
www.hhs.gov/ohrp/sachrp/.
Dated: June 20, 2007.
Bernard A. Schwetz,
Director, Office for Human Research Protections, Executive Secretary,
Secretary's Advisory Committee on Human Research Protections.
[FR Doc. E7-12229 Filed 6-22-07; 8:45 am]
BILLING CODE 4150-36-P